Answers are grounded in this paper and cite their sources.
Objective To study the effect of dexmedetomidine on the immune system function and inflammatory factors in postoperative patients with septic Shock. Methods From October 2012 to October 2013, 84 patients in our hospital undergoing surgery for septic Shock were divided into two groups according random-number table(n=42 each): dexmedetomidine group and control group(propofol). The levels of immune cells(CD3+, CD4+, CD4+ /CD8+)of two groups were determined with Beckm Epics flow cytometry at time of preoperation, postoperation, and 1, 3, 7days after operation, the levels of C-reactive proteinl(CRP) were determined with Immunoturbidimetry, and the levels interleukin(IL)-6, IL-8 were determined with enzyme-linked immanosorbent assay(ELISA). Results The rate of postoperative cognitive dysfunction(POCD) in dexmedetomidine group is lower than control group(propofol)(4.76% vs 23.89%, P=0.013); the rate of postoperative infection is lower than control group(propofol)(2.38 vs21.43, P=0.0007); the levels of CD3+, CD4+, CD4+ /CD8+ in two groups are both higher than the dexmedetomidine group; the levels of CRP and IL-6, IL-8 in two groups are both lower than the dexmedetomidine group. Conclusion Dexmedetomidine has less effect on immune system functon in patients with setic Shock, and can reduce the rate of post operatove congnitive dysfuncition(POCD) and the rate of perioperative infection incidence by reducing the effects of inflammation on the body.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: